These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8602659)
1. Comparison of the segregation of the RYR1 C184OT mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family. Hogan K Anesthesiology; 1996 Feb; 84(2):29A-30A. PubMed ID: 8602659 [No Abstract] [Full Text] [Related]
2. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family. Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662 [TBL] [Abstract][Full Text] [Related]
3. No C1840 to T mutation in RYR1 in malignant hyperthermia. Hall-Curran JL; Stewart AD; Ball SP; Halsall JP; Hopkins PM; Ellis FR Hum Mutat; 1993; 2(4):330. PubMed ID: 8401544 [No Abstract] [Full Text] [Related]
4. A case of discordance between genotype and phenotype in a malignant hyperthermia family. Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931 [TBL] [Abstract][Full Text] [Related]
6. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary]. Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family. Steinfath M; Seranski P; Singh S; Fiege M; Wappler F; Schulte Am Esch J; Scholz J Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):372-5. PubMed ID: 12237752 [TBL] [Abstract][Full Text] [Related]
8. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle]. Monnier N; Lunardi J Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701 [TBL] [Abstract][Full Text] [Related]
9. Ryanodine receptor mutations in malignant hyperthermia and central core disease. McCarthy TV; Quane KA; Lynch PJ Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202 [TBL] [Abstract][Full Text] [Related]
13. Genetic analysis with calcium-induced calcium release test in Japanese malignant hyperthermia susceptible (MHS) families. Maehara Y; Mukaida K; Hiyama E; Morio M; Kawamoto M; Yuge O Hiroshima J Med Sci; 1999 Mar; 48(1):9-15. PubMed ID: 10213958 [TBL] [Abstract][Full Text] [Related]
14. Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes. Keating KE; Giblin L; Lynch PJ; Quane KA; Lehane M; Heffron JJ; McCarthy TV J Med Genet; 1997 Apr; 34(4):291-6. PubMed ID: 9138151 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia. Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621 [TBL] [Abstract][Full Text] [Related]
16. Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene. Deufel T; Sudbrak R; Feist Y; Rübsam B; Du Chesne I; Schäfer KL; Roewer N; Grimm T; Lehmann-Horn F; Hartung EJ Am J Hum Genet; 1995 Jun; 56(6):1334-42. PubMed ID: 7762556 [TBL] [Abstract][Full Text] [Related]
17. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation. Fletcher JE; Calvo PA; Rosenberg H Br J Anaesth; 1993 Sep; 71(3):410-7. PubMed ID: 8398525 [TBL] [Abstract][Full Text] [Related]
18. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model. Wehner M; Rueffert H; Koenig F; Olthoff D Neuromuscul Disord; 2004 Jul; 14(7):429-37. PubMed ID: 15210166 [TBL] [Abstract][Full Text] [Related]
19. [Malignant hyperthermia--a hereditary and potentially life-threatening condition]. Haugen T; Toft M; Müller CR; Aasly J Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682 [TBL] [Abstract][Full Text] [Related]
20. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. Richter M; Schleithoff L; Deufel T; Lehmann-Horn F; Herrmann-Frank A J Biol Chem; 1997 Feb; 272(8):5256-60. PubMed ID: 9030597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]